Cartesian Therapeutics Inc (RNAC)

CapEx to Revenue

141.03%

TTM · Retrieved:

RNAC logo

RNAC CapEx to Revenue

Current (TTM)141.03%
RNAC TTM CapEx/Revenue (141.03% → 141.03%)
More history is needed to export this chart.

RNAC capex to revenue history

Published TTM snapshot. The date records when this current TTM value was retrieved.

Cartesian Therapeutics Inc CapEx to Revenue — Published TTM snapshot
RetrievedCapEx to Revenue
141.0291%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.